1. |
Li Y, Nichols MA, Shay JW, et al. Transcriptional repression of the Dtype cyclindependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product PRb 〔J〕. Cancer Res, 1994; 54(23)∶6078.
|
2. |
Fromowitz FB, Viola MV, Chao S, et al. Res p21 expression in the progression of breast cancer 〔J〕. Human Pathol, 1987; 18(12)∶1268.
|
3. |
王翠芳,騰猛,李迎旭等. p16蛋白在甲狀腺癌的表達或缺失的意義 〔J〕. 中國腫瘤臨床, 1998; 25(3)∶221.
|
4. |
Serano M, Hannon GJ, Becach D. A new regulatory motif in cellcycle control causing specific inhibition of cyclin D/CDK4 〔J〕. Nature, 1993; 336(6456)∶704.
|
5. |
Kamb A, Gruis NA, WeaverFeldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types 〔J〕. Science, 1994; 264(5157)∶436.
|
6. |
Zou MU, Shi YE, Farid NR. Retinoblastoma gene defects are control to thyroid carcinogenesis 〔C〕. Endocrine Society Meeting, 1993∶91-4.
|
7. |
Holm R, Nesland JM. Retinoblastoma and p53 tumor suppressor gene protein expression in carcinomas of the thyroid gland 〔J〕. J Pathol, 1994; 172(3)∶267.
|
8. |
Xu HJ, Hu SX, Cagle PT, et al. Absence of retinoblastoma protein in primary nonsmallcell lung carcinomas 〔J〕. Cancer Res, 1991; 51(10)∶ 2735.
|